North America Hyperpigmentation Disorder Treatment Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Hyperpigmentation Disorder Treatment Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Hyperpigmentation Disorder Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Hyperpigmentation Disorder Treatment Market Regional Analysis

6.2 North America Hyperpigmentation Disorder Treatment Market Revenue 2020-2030 (US$ Million)

6.3 North America Hyperpigmentation Disorder Treatment Market Forecast Analysis

7. North America Hyperpigmentation Disorder Treatment Market Analysis – by Treatment Type

7.1 Cosmeceutical

7.1.1 Overview
7.1.2 Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Light or Laser Therapy

7.2.1 Overview
7.2.2 Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Microdermabrasion

7.3.1 Overview
7.3.2 Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Chemical Peels

7.4.1 Overview
7.4.2 Chemical Peels: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.5 Cryotherapy

7.5.1 Overview
7.5.2 Cryotherapy: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. North America Hyperpigmentation Disorder Treatment Market Analysis – by Condition

8.1 Melasma

8.1.1 Overview
8.1.2 Melasma: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Solar Lentigines

8.2.1 Overview
8.2.2 Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Post-inflammatory Hyperpigmentation

8.3.1 Overview
8.3.2 Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. North America Hyperpigmentation Disorder Treatment Market – North America Analysis

9.1 Overview

9.2 North America

9.2.1 North America Hyperpigmentation Disorder Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
9.2.1.1 North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
9.2.1.1 US: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.1.1 US: North America Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.2.1.1.2 US: North America Hyperpigmentation Disorder Treatment Market Breakdown, by Condition

9.2.1.2 Canada: North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.2.1 Canada: North America Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.2.1.2.2 Canada: North America Hyperpigmentation Disorder Treatment Market Breakdown, by Condition

9.2.1.3 Mexico : North America Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9.2.1.3.1 Mexico : North America Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.2.1.3.2 Mexico : North America Hyperpigmentation Disorder Treatment Market Breakdown, by Condition

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 AbbVie Inc

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Bayer AG

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Galderma SA

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 L'OREAL S.A.

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Lutronic Co Ltd

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Obagi Cosmeceuticals LLC

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Vivier Pharma Inc

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Pierre Fabre Group

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

North America Hyperpigmentation Disorder Treatment Market

Analysis - by Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-inflammatory Hyperpigmentation, and Others), and End User (Hospitals, Dermatology Centers, and Others)